Showing 191-200 of 9671 results for "".
DermWireTV: Cassiopeia Winlevi; Psoriasis Guidelines; Cyndi Lauper's PsO in the Know; Sarah Michelle Gellar's CoolSculpting
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cassiopeia-winlevi-psoriasis-guidelines-cyndi-laupers-pso-in-the-know-sarah-michelle-gellars-coolsculpting/19852/The FDA has approved Winlevi (Clascoterone cream 1%) from Cassiopea for the treatment of acne in patients 12 years and older.New Guidelines of care for the Management of Psoriasis with Systemic Nonbiologic Therapies, jointly issued by the American Academy of Dermatology and the National Psoriasis FoCOVID-19 Will Eventually End, But Telemedicine is Here to Stay
https://practicaldermatology.com/topics/practice-management/covid-19-will-eventually-end-but-telemedicine-is-here-to-stay/23348/As dermatology practices consider next steps regarding virtual care visits, it’s important to look beyond the basic platforms and establish a safer, more userfriendly telemedicine strategy.How Does Consideration of the Microbiome Affect Topical Product Selection
https://practicaldermatology.com/topics/atopic-dermatitis/how-does-consideration-of-the-microbiome-affect-topical-product-selection/19827/A healthy microbiome is a hallmark of healthy skin, while dysbiosis is implicated in various dermatologic diseases. Dr. Friedman explains how this knowledge should influence topical skin care.Setting Compensation Expectations for Non-Surgical Providers
https://practicaldermatology.com/topics/practice-management/setting-compensation-expectations-for-non-surgical-providers/23227/It’s important that all parties understand the actual costs associated with a position in order to set realistic revenue goals.Dermatology chatbots 101
https://practicaldermatology.com/topics/practice-management/dermatology-chatbots-101/19743/Could an artificial intelligence powered chatbot improve your dermatology website? Find out in this Ekwa Marketing video.Social Media Use By Medical Providers: Risk, Benefit, Ethical Quandaries
https://practicaldermatology.com/topics/practice-management/social-media-use-by-medical-providers-risk-benefit-ethical-quandaries/23174/Those who treat patients may use social media in professional settings, but caution is in order.How to Get Job Seekers to Apply to Your Job
https://practicaldermatology.com/topics/practice-management/how-to-get-job-seekers-to-apply-to-your-job/23152/Learn the secrets to getting qualified physicians to apply to your job.Systemic Treatment for Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/systemic-treatment-for-skin-cancers/19662/Anisha B. Patel, MD discusses the latest advances in systemic treatment for melanoma with host Joshua Zeichner, MD. She reviews how treatments work, the most common cutaneous reactions patients experience, and the dermatologist's role in managing those reactions and reassuring patients that these reBiologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Treating Moderate to Severe Psoriasis: Weighing the Treatment Options
https://practicaldermatology.com/topics/psoriasis/-treating-moderate-to-severe-psoriasis-weighing-the-treatment-options/18375/In part 2 of her interview with DermTube Journal Club host Joshua Zeichner, MD, Erin Boh, MD reviews new biologics that provide patients with moderate to severe psoriasis improved treatment options. She discusses their efficacy and safety and offers tips for finding the right one for each patient ba